Exagen elects frank stokes to board of directors

San diego, june 18, 2021 (globe newswire) -- exagen inc. (nasdaq: xgn), a leading provider of autoimmune testing solutions, is proud to announce the company's stockholders approved the election of mr. frank stokes as an additional independent member to its board of directors at the annual meeting held on june 17, 2021. mr. stokes will also serve as chair of the audit committee.
XGN Ratings Summary
XGN Quant Ranking